(E)-5-(2-Bromovinyl)-2'-deoxy-4'-thiouridine (S-BVDU) is a potent antiherpesvirus agent and its use in gene therapy as an anticancer agent has recently been described. We here outline 2 efficient methods for the synthesis of S-BVDU. The decision as to which method is to be used depends upon the starting materials available but starting from BVU, an overall yield of beta-nucleoside of 35% can be expected. From 5-ethyl-2'-deoxy-4'-thiouridine, radical bromination using bromine will give a quantitative conversion to S-BVDU if unreacted starting material is recycled (50%) or using N-bromosuccinimide, a one step yield in excess of 80% can be obtained.
Efficient Syntheses of (E)-5-(2-Bromovinyl)-2'-deoxy-4'-thiouridine; a Nucleoside Analogue with Potent Biological Activity.-Two efficient, alternative routes to the synthesis of the title thiouridine [cf. protected precursors (VII) and (X)], one of the most potent and selective antiherpesvirus compounds known, are developed. -(BASNAK, I.; OTTER, G. P.; DUN-COMBE, R. J.; WESTWOOD, N. B.; PIETRARELLI, M.; HARDY, G. W.; MILLS, G.; RAHIM, S. G.; WALKER, R. T.; Nucleosides Nucleotides 17 (1998) 1-3, 29-38; Sch. Chem., Univ. Birmingham, Edgbaston, Birmingham B15 2TT, UK; EN)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.